Discovery sheds light on Alzheimer's mystery

by April Reese Sorrow

(Medical Xpress)—In 1906, when Alois Alzheimer discovered the neurodegenerative disease that would later be named for him, he saw amyloid-beta plaques and neurofibrillary tangles inside the brain. Several decades later, abnormal protein structures called Hirano bodies also were frequently observed in patients with neurodegenerative diseases.

A hundred years and many millions of suffering patients and families later, scientists still don't know what these structures do. They do know, thanks to new research from the University of Georgia, that Hirano bodies may have a protective role in the brain of Alzheimer's patients.

Matthew Furgerson, a doctoral candidate in the UGA Franklin College of Arts and Sciences department of biochemistry and molecular biology, used cell culture models to study the role of Hirano bodies in induced by AICD, or a fragment of AICD called c31, that are released inside the cell during cleavage of the amyloid . This cleavage also produces amyloid-beta, which forms extracellular plaques.

Furgerson found mixtures of amyloid precursor protein, c31 and tau-the protein that forms the intracellular neurofibrillary tangles-or of AICD and tau cause synergistic cell death that is significantly higher than cell death from amyloid precursor protein, c31, AICD or tau alone.

"This synergistic cell death is very exciting," Furgerson said. "Other groups have shown synergy between extracellular amyloid beta or with tau, but these new results show that there may be an important interaction that occurs inside the cells."

The results of this study were published in the September issue of . Ruth Furukawa, associate research scientist, and Marcus Fechheimer, professor of , are co-authors on the paper.

Furgerson also found cell death is significantly reduced in cells that contain Hirano bodies compared to cells without Hirano bodies. The protective effect of Hirano bodies was observed in in both the presence and absence of tau. The findings reveal that Hirano bodies have a protective role during the progression of Alzheimer's disease.

While this research offers no cure for the disease, it does offer some understanding about how the disease operates. The lab has been a leader of Hirano body research for more than a decade due to their development of cell culture and mouse model systems.

Before the mouse model, the only way to study these abnormal structures was in post-mortem brain tissue. The recently developed Hirano body mouse model is currently being used with an Alzheimer's model mouse to investigate whether cell culture results can translate to a complex animal.

"I feel privileged to lead a team that might be able to contribute knowledge to help us understand Alzheimer's disease processes," Fechheimer said. "Other groups have focused on plaques and tangles, and we don't know as much about Hirano bodies. Results from the cell culture studies are exciting and reveal the protective role of Hirano bodies. Our ongoing studies with mouse models are essential to defining the role of Hirano bodies in Alzheimer's disease progression in a whole animal."

More information: www.ncbi.nlm.nih.gov/pmc/articles/PMC3445605/

Related Stories

Road block as a new strategy for the treatment of Alzheimer's

Aug 22, 2011

Blocking a transport pathway through the brain cells offers new prospects to prevent the development of Alzheimer's. Wim Annaert and colleagues of VIB and K.U. Leuven discovered that two main agents involved in the inception ...

Alzheimer's vaccine cures memory of mice

Dec 09, 2011

(Medical Xpress) -- A vaccine that slows the progression of Alzheimer's disease and other types of dementia has been developed by researchers at the University of Sydney's Brain and Mind Research Institute ...

Recommended for you

Improving the quality of dementia care

Nov 20, 2014

Healthcare workers and facilitators caring for persons suffering with dementia have expressed their satisfaction with new forms of mobile phone apps which are designed to assist support carers in residential homes to be more ...

Brain receptor cell could be new target for Alzheimer's

Nov 18, 2014

Blocking a key receptor in brain cells that is used by oxygen free radicals could play a major role in neutralizing the biological consequences of Alzheimer's disease, according to researchers at Temple University.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.